Cynthia Ma, MD, PhD

Vice President
2024-2026

Dr. Cynthia Ma is a breast oncologist and a physician scientist, with research focuses on endocrine therapy and targeted agents for the treatment of breast cancer.  She has led several biomarker directed, investigator initiated trials including neoadjuvant studies of endocrine agents in combination with inhibitors against PI3K pathway or the CDK4/6 in patients with locally advanced estrogen receptor positive breast cancer.  She is the study chair for the ongoing ALLIANCE ALTERNATE trial, which evaluates Ki67 based biomarkers as well as genomic predictors of endocrine responsiveness.  She is the clinical director of the Breast Cancer Program in Medical Oncology at Washington University School of Medicine and a member of the Alliance Breast Committee.